Legacy Advisors, LLC
Position in TMO — Thermo Fisher Scientific Inc.
CIK 1720969
PLYMOUTH MEETING, PA
Position in TMO
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$355,965
+$43,844 QoQ
Shares Held
710
+11.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,950
of 2,606 holders
Holding Since
Mar 2022
16 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Legacy Advisors, LLC holds $1,217,374 across 3 Diagnostics & Research names. TMO ranks #3 (29.2% of the industry book) .
All Filings in TMO
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $355,965 | 710 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $312,121 | 635 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $406,773 | 702 | Shares | Sole | 2026-01-27 | |
| 2025-03-31 | $1,493,795 | 3,002 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $1,472,250 | 2,830 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,819,832 | 2,942 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,578,262 | 2,854 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $1,675,047 | 2,882 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $2,407,663 | 4,536 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $3,142,809 | 6,209 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,323,025 | 6,369 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $3,772,341 | 6,545 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $3,429,146 | 6,227 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $2,570,438 | 5,068 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,390,432 | 4,400 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $2,196,036 | 3,718 | Shares | Sole | 2022-05-11 | |
| No filing history on record for this holder in this stock. | ||||||